ZA200906850B - Process for production of prasugrel hydrochloride having high purity - Google Patents

Process for production of prasugrel hydrochloride having high purity

Info

Publication number
ZA200906850B
ZA200906850B ZA200906850A ZA200906850A ZA200906850B ZA 200906850 B ZA200906850 B ZA 200906850B ZA 200906850 A ZA200906850 A ZA 200906850A ZA 200906850 A ZA200906850 A ZA 200906850A ZA 200906850 B ZA200906850 B ZA 200906850B
Authority
ZA
South Africa
Prior art keywords
production
high purity
prasugrel hydrochloride
prasugrel
hydrochloride
Prior art date
Application number
ZA200906850A
Other languages
English (en)
Inventor
Hiroyuki Miyata
Yukinori Wada
Naoyuki Yokota
Original Assignee
Daiichi Sankyo Co Ltd
Ube Industries
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39738173&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200906850(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Daiichi Sankyo Co Ltd, Ube Industries filed Critical Daiichi Sankyo Co Ltd
Publication of ZA200906850B publication Critical patent/ZA200906850B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
ZA200906850A 2007-03-02 2009-10-01 Process for production of prasugrel hydrochloride having high purity ZA200906850B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007053093 2007-03-02

Publications (1)

Publication Number Publication Date
ZA200906850B true ZA200906850B (en) 2010-06-30

Family

ID=39738173

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200906850A ZA200906850B (en) 2007-03-02 2009-10-01 Process for production of prasugrel hydrochloride having high purity

Country Status (25)

Country Link
US (2) US20100094013A1 (fr)
EP (1) EP2123656B1 (fr)
JP (1) JP5363307B2 (fr)
KR (1) KR101505212B1 (fr)
CN (2) CN101675058A (fr)
AU (1) AU2008222000B2 (fr)
BR (1) BRPI0808034A2 (fr)
CA (1) CA2679925C (fr)
CO (1) CO6210821A2 (fr)
CY (1) CY1115518T1 (fr)
DK (1) DK2123656T3 (fr)
ES (1) ES2487190T3 (fr)
HK (1) HK1136278A1 (fr)
HR (1) HRP20140668T1 (fr)
IL (1) IL200647A (fr)
MX (1) MX2009009413A (fr)
MY (1) MY151726A (fr)
NZ (1) NZ579993A (fr)
PL (1) PL2123656T3 (fr)
PT (1) PT2123656E (fr)
RU (1) RU2435776C2 (fr)
SI (1) SI2123656T1 (fr)
TW (1) TWI417295B (fr)
WO (1) WO2008108291A1 (fr)
ZA (1) ZA200906850B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2855700T3 (es) 2007-04-27 2021-09-24 Cydex Pharmaceuticals Inc Formulaciones que contienen clopidogrel y sulfoalquil éter-ciclodextrina y métodos de uso
EP2205611A4 (fr) * 2007-11-09 2012-02-22 Reddys Lab Ltd Dr Procédés de préparation de prasugrel et ses sels et polymorphes
CN101684124B (zh) * 2008-09-22 2013-11-13 广州赫尔氏药物开发有限公司 新的具有抗凝血作用的化合物
CN103936756B (zh) * 2008-09-22 2017-09-19 广州赫尔氏药物开发有限公司 具有抗凝血作用的化合物
CN101486635B (zh) * 2009-02-27 2012-10-10 上海医药工业研究院 α-环丙基羰基-2-氟苄基卤素的制备方法
CN104606681B (zh) * 2009-05-13 2018-08-21 锡德克斯药物公司 包含普拉格雷和环糊精衍生物的药物组合物及其制备和使用方法
CN101993447A (zh) * 2009-08-26 2011-03-30 浙江华海药业股份有限公司 一种人工合成普拉格雷的方法
HU229035B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel
HU229031B1 (en) 2009-12-21 2013-07-29 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Process for producing prasurgel and its intermediate
CN101735241A (zh) * 2009-12-24 2010-06-16 浙江普洛家园药业有限公司 普拉格雷中间体及其制备方法
CN102869668A (zh) 2010-03-09 2013-01-09 斯索恩有限公司 制备普拉格雷的方法
EP2528924A1 (fr) * 2010-03-23 2012-12-05 Alembic Pharmaceuticals Limited Procédé de préparation du sel hcl de prasugrel
WO2012001486A1 (fr) * 2010-06-28 2012-01-05 Mayuka Labs Pvt. Ltd. Procédé perfectionné pour la préparation de chlorhydrate de prasugrel et de ses intermédiaires
WO2012018791A2 (fr) * 2010-08-06 2012-02-09 Dr. Reddy's Laboratories Ltd. Préparation de chlorhydrate de prasugrel
CN101948479B (zh) * 2010-09-29 2013-01-30 横店集团家园化工有限公司 普拉格雷中间体及其制备方法
HUP1000565A2 (en) 2010-10-22 2012-05-02 Egis Gyogyszergyar Nyrt Process for the preparation of pharmaceutically active compound and intermediers
CN102101827B (zh) * 2010-11-15 2013-07-03 山东新华制药股份有限公司 一种普拉格雷中间体α-环丙羰基-2-氟苄基卤的制备方法
CN103517909B (zh) * 2011-04-14 2015-04-08 广州赫尔氏药物开发有限公司 新型抗血小板化合物的加成盐
CN102746318A (zh) * 2011-04-20 2012-10-24 上海信谊药厂有限公司 用于制备普拉格雷盐酸盐的方法
CN102276623A (zh) * 2011-06-13 2011-12-14 安徽省虹升生物科技有限公司 一种利用有机硅保护剂进行制备普拉格雷的新方法
CN102838618A (zh) 2011-06-22 2012-12-26 广东东阳光药业有限公司 一种制备普拉格雷的方法及普拉格雷盐酸盐新晶型
WO2013024399A1 (fr) * 2011-08-12 2013-02-21 Alembic Pharmaceuticals Limited Procédé amélioré de détermination quantitative du prasugrel chlorhydrate
CN102977115B (zh) * 2012-11-16 2015-01-21 江苏先声药业有限公司 普拉格雷游离碱的合成新方法
CN105085541A (zh) * 2014-05-07 2015-11-25 江苏先声药业有限公司 一种普拉格雷类似物的制备方法
HU231079B1 (hu) 2016-06-23 2020-06-29 Richter Gedeon Nyrt. Eljárás nagytisztaságú Prasugrel előállítására bromopentil szennyezés eltávolításával
CN112047959A (zh) * 2020-10-21 2020-12-08 深圳市祥根生物科技有限公司 一种普拉格雷开环氯代杂质的制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI101150B (fi) * 1991-09-09 1998-04-30 Sankyo Co Menetelmä lääkeaineina käyttökelpoisten tetrahydrotienopyridiinin johd annaisten valmistamiseksi
EP0785205B1 (fr) * 1994-10-07 2002-04-17 Ube Industries, Ltd. 2-silyloxytetrahydrothienopyridine, son sel, et son procede de production
KR20130118395A (ko) * 2000-07-06 2013-10-29 다이이찌 산쿄 가부시키가이샤 히드로피리딘 유도체 산부가염
JP4001199B2 (ja) * 2000-07-06 2007-10-31 第一三共株式会社 ヒドロピリジン誘導体酸付加塩
DE60135780D1 (de) * 2000-12-25 2008-10-23 Daiichi Sankyo Co Ltd Aspirin enthaltende medizinische zusammensetzungen
JP4029974B2 (ja) * 2001-12-21 2008-01-09 第一三共株式会社 ヒドロピリジン誘導体酸付加塩を含有する医薬
WO2004098713A2 (fr) * 2003-05-05 2004-11-18 Eli Lilly And Company Methode de traitement de maladies cardio-vasculaires
TWI318571B (en) * 2005-06-10 2009-12-21 Lilly Co Eli Formulation of a thienopyridine platelet aggregation inhibitor
TWI392681B (zh) * 2006-04-06 2013-04-11 Daiichi Sankyo Co Ltd 高純度普拉格雷及其酸加成鹽之製法

Also Published As

Publication number Publication date
KR20090127267A (ko) 2009-12-10
CA2679925A1 (fr) 2008-09-12
MX2009009413A (es) 2009-09-11
TWI417295B (zh) 2013-12-01
SI2123656T1 (sl) 2014-09-30
CA2679925C (fr) 2012-10-02
CO6210821A2 (es) 2010-10-20
HK1136278A1 (en) 2010-06-25
ES2487190T3 (es) 2014-08-20
AU2008222000B2 (en) 2012-06-14
JP5363307B2 (ja) 2013-12-11
PT2123656E (pt) 2014-09-08
PL2123656T3 (pl) 2014-11-28
TW200844104A (en) 2008-11-16
CN101675058A (zh) 2010-03-17
RU2009136445A (ru) 2011-04-10
RU2435776C2 (ru) 2011-12-10
WO2008108291A1 (fr) 2008-09-12
EP2123656A4 (fr) 2011-05-04
US20130345428A1 (en) 2013-12-26
CN102424686A (zh) 2012-04-25
MY151726A (en) 2014-06-30
DK2123656T3 (da) 2014-09-08
EP2123656B1 (fr) 2014-06-11
NZ579993A (en) 2012-06-29
US20100094013A1 (en) 2010-04-15
IL200647A (en) 2015-02-26
AU2008222000A1 (en) 2008-09-12
CY1115518T1 (el) 2017-01-04
EP2123656A1 (fr) 2009-11-25
IL200647A0 (en) 2010-05-17
HRP20140668T1 (hr) 2014-10-10
BRPI0808034A2 (pt) 2014-06-17
JPWO2008108291A1 (ja) 2010-06-17
KR101505212B1 (ko) 2015-03-23

Similar Documents

Publication Publication Date Title
HK1136278A1 (en) Process for production of prasugrel hydrochloride having high purity
SI2003136T1 (sl) Postopek za pridobivanje prasugrel hidroklorida visoke čistosti
EP2123625A4 (fr) Polymorphe cristallin de dérivé de fluorène et son procédé de fabrication
IL191125A0 (en) Process for production of cinnamide derivative
SI2144851T1 (sl) Postopek za proizvodnjo pcc
IL199295A (en) Process for the production of an anthranilamide compound
EP2267143A4 (fr) Procédés de production de composés amides
EP2169075A4 (fr) Procédé de fabrication d'un alcaloïde
EP2025719A4 (fr) Procede de fabrication d'un compose azo
EP2133356A4 (fr) Procédé de fabrication d'un acide -céto contenant du phosphore
EP2017262A4 (fr) Procede de production de carotenoide
EP2088136A4 (fr) Procédé de fabrication d'hydroxyadamantane-amine
EP2292579A4 (fr) Procédé pour la fabrication d' -fluoroéthers halogénés
EP1990336A4 (fr) Procede de production d'un compose 5-alcoxy-4-hydroxymethylpyrazole
IL187155A0 (en) Process for production of 4-biphenylazetidin-2-ones
EP2256102A4 (fr) Procédé de fabrication d'un composé alcoxycarbonyle
EP2096103A4 (fr) Procédé pour la production d'une bétaïne
ZA200710066B (en) Process for production of 4-biphenylylazetidin-2-ones
EP2221294A4 (fr) Procédé de production de n-carbamoyl-tert-leucine
HK1152033A1 (en) Process for production of thiophene compound and intermediate thereof
IL200281A0 (en) Process for production of tablet
EP2216411A4 (fr) Procédé de fabrication d'un composé pyrrole
EP2085403A4 (fr) Procédé de production de peptide thioester
EP1988073A4 (fr) Procédé de production d'un dérivé de beta-amino-alpha-hydroxyacide de type amide
EP2251329A4 (fr) Procédé de fabrication de la 3-amino-2-chloro-6- trifluorométhylpyridine